• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Pakistan Pharmaceuticals and Healthcare Report Q1 2011 - Product Image

Pakistan Pharmaceuticals and Healthcare Report Q1 2011

  • Published: November 2010
  • Region: Pakistan
  • 94 Pages
  • Business Monitor International

FEATURED COMPANIES

  • Ferozsons Laboratories
  • Getz Pharma
  • GlaxoSmithKline (GSK)
  • Hilton Pharma
  • Novartis
  • Pacific Pharmaceuticals
  • MORE

Pakistan Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on Pakistan's pharmaceuticals and healthcare industry.

In BMI’s Asia Pacific Business Environment Ratings (BERs) for Q111, Pakistan remains 16th, having dropped one place compared with the previous quarter due to the addition of a more attractive market – Sri Lanka – to their proprietary ratings system. Globally, Pakistan ranks 75th of the 83 markets surveyed. While its fundamentals may sound attractive (large population and emerging economy), Pakistan is at risk of experiencing years of instability and militant activity, although an outright collapse of the state is unlikely unless the core province of Punjab becomes ungovernable. Meanwhile, due to its strategic importance, Pakistan's foreign allies will do everything they can to ensure its stability, although foreign drugmakers will continue to take a cautious stance regarding direct investment in the country.

BMI calculate that the total value of prescription READ MORE >

Executive Summary
SWOT Analysis
Pakistan Pharmaceutical Industry SWOT
Pakistan Political SWOT
Pakistan Economic SWOT
Pakistan Business Environment SWOT
Pharmaceutical Business Environment Ratings
Table: Asia Pacific Pharmaceutical Business Environment Ratings, Q111
Rewards
Risks
Pakistan – Market Summary
Regulatory Regime
Recent Regulatory Developments
Intellectual Property Regime
Shortcomings Of The Intellectual Property Environment
Counterfeit Drugs
Pricing Regime
Reimbursement Regime
Recent Pricing and Reimbursement Regime Developments
Industry Trends And Developments
Epidemiology
Non-Communicable Diseases
Communicable Diseases
Recent Public Health Developments
Healthcare System
Table: Pakistan – Key Healthcare Statistics, 2007 (‘000 people, unless otherwise stated)
Healthcare Insurance
Medical Tourism
Traditional Medicine
Research And Development
International Cooperation
Medical Devices
Industry Forecast Scenario
Pharmaceutical Market Forecast
Table: Pakistan – Pharmaceutical Market Indicators, Historical Data and Forecasts, 2006-2014
Key Growth Factors – Industry
Table: Pakistan – Healthcare Expenditure Trends, Historical Data and Forecasts, 2006-2014
Key Growth Factors – Macroeconomic
Table: Pakistan – Economic Activity, 2007-2014
Prescription Drug Market Forecast
Table: Pakistan – Prescription Drug Market Indicators, Historical Data and Forecasts, 2006-2014
Patented Drug Market Forecast
Table: Pakistan – Patented Drug Market Indicators, Historical Data and Forecasts, 2006-2014
Generic Drug Market Forecast
Table: Pakistan – Generics Drug Market Indicators, Historical Data and Forecasts, 2006-2014
OTC Medicine Market Forecast
Table: Pakistan – OTC Medicine Market Indicators, Historical Data and Forecasts, 2006-2014
Medical Device Market Forecast
Table: Pakistan – Medical Device Market Indicators, Historical Data and Forecasts, 2006-2014
Pharmaceutical Trade Forecast
Table: Pakistan – Pharmaceutical Trade Data And Forecasts , 2006-2014
Other Healthcare Data Forecasts
Key Risks To BMI’s Forecast Scenario
Competitive Landscape
Pharmaceutical Sector
2008 Financial Snapshot Of Pakistani Drugmakers Listed On The Karachi Stock Exchange (US$mn)
Table: Pakistan – Leading Pharmaceutical Players (2009)
Domestic Pharmaceutical Industry
Foreign Pharmaceutical Industry
Recent Pharmaceutical Sector Developments
Pharmaceutical Distribution Sector
Company Monitor
Local Manufacturers
Searle Pakistan
Hilton Pharma
Efroze Chemical Industries
Ferozsons Laboratories
Getz Pharma
Pacific Pharmaceuticals
Leading Multinational Manufacturers
GlaxoSmithKline (GSK)
Pfizer
Abbott Laboratories
Novartis
Sanofi-Aventis
Wyeth
Country Snapshot: Pakistan Demographic Data
Section 1: Population
Table: Demographic Indicators, 2005-2030
Table: Rural/Urban Breakdown, 2005-2030
Section 2: Education and Healthcare
Table: Education, 2002-2005
Table: Vital Statistics, 2005-2030
Table: Employment Indicators, 2001-2006
Section 3: Labour Market And Spending Power
Table: Consumer Expenditure, 2000-2012 (US$)
Table: Average Annual Manufacturing Wages, 2000-2012
BMI Methodology
How We Generate Our Pharmaceutical Industry Forecasts
Pharmaceuticals Business Environment Ratings
Risk/Reward Ratings Methodology
Ratings Overview
Table: Pharmaceutical Business Environment Indicators
Weighting
Table: Weighting Of Components
Sources

- Searle Pakistan
- Hilton Pharma
- Efroze Chemical Industries
- Ferozsons Laboratories
- Getz Pharma
- Pacific Pharmaceuticals
- GlaxoSmithKline (GSK)
- Pfizer
- Novartis
- Sanofi-Aventis
- Wyeth

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos